The Next Generation of Soft Tissue Support

The Galatea scaffold collection is designed specifically for strength retention throughout the critical wound healing period [1,19] and provides a lattice for new tissue ingrowth. [16] As the scaffold bioresorbs, the new ingrown tissue provides strength to repair the site. [19] By 52 weeks, the ingrown tissue is approximately 2.4 mm thick and provides the majority of repair strength.[2,23]

Watch the Galatea Scaffold Collection Overview.

Preclinical studies have indicated that Galatea scaffold maintains greater than 70% of its strength at 12 weeks in vivo[2] that gradually and predictably bioresorbs over the course of approximately 18-24 months. [2,12]

Designed specifically for strength retention throughout the critical wound healing period [1,19] Rapid tissue regeneration resulting in a new tissue plane approximately 3-4 times the strength of native tissue as demonstrated in pre-clinical studies [9,19] Galatea Scaffolds are naturally bioresorbed, leaving behind only strong healthy tissue to support the surgical outcome. [2,12]

There is a predictable reduction in polymer molecular weight and corresponding decrease in scaffold strength over time.

Hydrolysis cross-section

P4HB degrades into 4HB, a natural metabolite endogenously found in the human brain, heart, kidney, liver, lung, muscle, and brown adipose tissue. The body rapidly catabolizes 4HB via the Krebs cycle and eliminates it as CO2 and H2O.